PO69 THE IMPACT OF MGMT METHYLATION AND IDH-1 MUTATION ON LONG TERM OUTCOME FOR GLIOBLASTOMA TREATED WITH CHEMORADIOTHERAPY

Benzer Materyaller

• Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
  Yazar:: Dunn, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
  Yazar:: Chai, Ruichao, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation
  Yazar:: Kessler, Tobias, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy
  Yazar:: Nguyen, HuyTram N., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
  Yazar:: Molenaar, Remco J., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)